Extract from the Register of European Patents

EP About this file: EP2099505

EP2099505 - BIOGEL [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  23.12.2016
Database last updated on 18.03.2026
Most recent event   Tooltip13.07.2018Lapse of the patent in a contracting state
New state(s): IS
published on 15.08.2018  [2018/33]
Applicant(s)For all designated states
HAEMOSTATIX LIMITED
BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF / GB
[2009/38]
Inventor(s)01 / WALKER, Greg
Haemostatix Limited
BioCity Nottingham
Pennyfoot Street
Nottingham NG1 1GF / GB
 [2016/07]
Former [2009/38]01 / WALKER, Greg
Haemostatix Limited BioCity Nottingham Pennyfoot Street
Nottingham NG1 1GF / GB
Representative(s)Adamson Jones
Park View House
58 The Ropewalk
Nottingham NG1 5DW / GB
[N/P]
Former [2016/07]Thornton, Neil
Reddie & Grose LLP
16 Theobalds Road
London
WC1X 8PL / GB
Former [2009/38]Thornton, Neil
Reddie & Grose 16 Theobalds Road London
WC1X 8PL / GB
Application number, filing date07824729.327.11.2007
[2009/38]
WO2007GB04538
Priority number, dateGB2006002360727.11.2006         Original published format: GB 0623607
[2009/38]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2008065388
Date:05.06.2008
Language:EN
[2008/23]
Type: A2 Application without search report 
No.:EP2099505
Date:16.09.2009
Language:EN
The application published by WIPO in one of the EPO official languages on 05.06.2008 takes the place of the publication of the European patent application.
[2009/38]
Type: B1 Patent specification 
No.:EP2099505
Date:17.02.2016
Language:EN
[2016/07]
Search report(s)International search report - published on:EP26.11.2009
ClassificationIPC:A61L24/10
[2009/38]
CPC:
A61K38/07 (EP,US); A61K9/0014 (US); A61L24/0015 (US);
A61L24/0031 (EP,US); A61L24/06 (US); A61L24/10 (US);
A61L24/106 (EP,US); A61P17/02 (EP); A61P7/04 (EP);
A61L2400/04 (US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2016/07]
Former [2009/38]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
TitleGerman:BIOGEL[2009/38]
English:BIOGEL[2009/38]
French:BIOGEL[2009/38]
Entry into regional phase26.06.2009National basic fee paid 
26.06.2009Designation fee(s) paid 
26.06.2009Examination fee paid 
Examination procedure26.06.2009Examination requested  [2009/38]
18.01.2010Amendment by applicant (claims and/or description)
14.08.2012Despatch of a communication from the examining division (Time limit: M06)
22.02.2013Reply to a communication from the examining division
12.02.2015Communication of intention to grant the patent
22.06.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.07.2015Communication of intention to grant the patent
24.11.2015Fee for grant paid
24.11.2015Fee for publishing/printing paid
11.12.2015Information about intention to grant a patent
11.12.2015Receipt of the translation of the claim(s)
Divisional application(s)EP16155589.1  / EP3095468
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  14.08.2012
Opposition(s)18.11.2016No opposition filed within time limit [2017/04]
Fees paidRenewal fee
12.10.2009Renewal fee patent year 03
12.11.2010Renewal fee patent year 04
14.11.2011Renewal fee patent year 05
13.11.2012Renewal fee patent year 06
18.11.2013Renewal fee patent year 07
10.11.2014Renewal fee patent year 08
10.11.2015Renewal fee patent year 09
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU27.11.2007
AT17.02.2016
BE17.02.2016
CY17.02.2016
CZ17.02.2016
EE17.02.2016
FI17.02.2016
IS17.02.2016
LT17.02.2016
LV17.02.2016
MC17.02.2016
RO17.02.2016
SI17.02.2016
SK17.02.2016
TR17.02.2016
BG17.05.2016
GR18.05.2016
PT17.06.2016
[2018/32]
Former [2018/29]HU27.11.2007
AT17.02.2016
BE17.02.2016
CY17.02.2016
CZ17.02.2016
EE17.02.2016
FI17.02.2016
LT17.02.2016
LV17.02.2016
MC17.02.2016
RO17.02.2016
SI17.02.2016
SK17.02.2016
TR17.02.2016
BG17.05.2016
GR18.05.2016
PT17.06.2016
Former [2018/28]HU27.11.2007
AT17.02.2016
BE17.02.2016
CY17.02.2016
CZ17.02.2016
EE17.02.2016
FI17.02.2016
LT17.02.2016
LV17.02.2016
MC17.02.2016
RO17.02.2016
SI17.02.2016
SK17.02.2016
BG17.05.2016
GR18.05.2016
PT17.06.2016
Former [2017/13]AT17.02.2016
BE17.02.2016
CZ17.02.2016
EE17.02.2016
FI17.02.2016
LT17.02.2016
LV17.02.2016
RO17.02.2016
SI17.02.2016
SK17.02.2016
BG17.05.2016
GR18.05.2016
PT17.06.2016
Former [2017/03]AT17.02.2016
BE17.02.2016
CZ17.02.2016
EE17.02.2016
FI17.02.2016
LT17.02.2016
LV17.02.2016
RO17.02.2016
SK17.02.2016
GR18.05.2016
PT17.06.2016
Former [2016/50]AT17.02.2016
CZ17.02.2016
EE17.02.2016
FI17.02.2016
LT17.02.2016
LV17.02.2016
RO17.02.2016
SK17.02.2016
GR18.05.2016
PT17.06.2016
Former [2016/49]AT17.02.2016
EE17.02.2016
FI17.02.2016
LT17.02.2016
LV17.02.2016
GR18.05.2016
PT17.06.2016
Former [2016/39]AT17.02.2016
FI17.02.2016
LT17.02.2016
LV17.02.2016
GR18.05.2016
PT17.06.2016
Former [2016/38]AT17.02.2016
FI17.02.2016
LT17.02.2016
GR18.05.2016
PT17.06.2016
Former [2016/36]AT17.02.2016
FI17.02.2016
LT17.02.2016
GR18.05.2016
Former [2016/35]FI17.02.2016
GR18.05.2016
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.